## Core Concept
Neostigmine is a **reversible cholinesterase inhibitor**, primarily used to improve muscle tone in patients with myasthenia gravis and to reverse the effects of non-depolarizing muscle relaxants. It works by increasing the concentration of acetylcholine in the synaptic cleft, thereby enhancing cholinergic transmission.

## Why the Correct Answer is Right
Neostigmine acts by inhibiting **acetylcholinesterase**, the enzyme responsible for the breakdown of acetylcholine. This inhibition leads to an accumulation of acetylcholine, which then stimulates **muscarinic and nicotinic receptors**. The increased stimulation of nicotinic receptors at the neuromuscular junction enhances muscle contraction, making neostigmine useful for treating myasthenia gravis and for reversing non-depolarizing neuromuscular blockers.

## Why Each Wrong Option is Incorrect
- **Option A:** Without the specific details of option A, it's not possible to directly address its accuracy. However, if it contains incorrect information about neostigmine's mechanism, indications, or pharmacological effects, it would be considered wrong based on the explanations provided.
- **Option B:** Similarly, without specifics, if option B suggests an incorrect aspect of neostigmine, such as a wrong receptor targeted or an incorrect clinical use, it would be deemed incorrect.
- **Option C:** This option's accuracy depends on its content. If it inaccurately describes neostigmine's pharmacodynamics, pharmacokinetics, or clinical applications, it would be incorrect.

## Clinical Pearl / High-Yield Fact
A key point to remember about neostigmine is its use in **reversing non-depolarizing muscle relaxants**. It's often administered at the end of surgeries to help patients regain muscle function. Additionally, neostigmine can cause **bradycardia** and **salivation** due to its muscarinic effects, and it is sometimes co-administered with **atropine** to mitigate these side effects.

## Correct Answer: D.